Winston Frazer learned it is not uncommon for soldiers and cops to remove their body armor, or simply not wear it regularly, because it is uncomfortable and unwieldy. It's a problem he thought his company’s 3D printing technology could help solve.
What if the uniforms worn by American soldiers could prevent them from getting badly injured by a fire, or from getting bitten by bugs that may carry disease? That kind of question drives Keturah Postell in her work, each day.
Early Charm, a company that creates, owns and operates ventures that convert science to revenue, today announced the hiring of Samuel Lahasky, PhD – a chemist with significant research and corporate product management experience – as Manager, Research Planning.
Early Charm Venture's portfolio company, SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced its Co-Founder and Chief Scientific Officer, Alexander D. MacKerell Jr., PhD, has co-led a study focusing on improving respiratory treatments via SilcsBio’s Site Identification by Ligand Competitive Saturation (SILCS) technology.
Early Charm Ventures today announced the hiring of Samir Rashiduddin – an experienced professional in accounting and business administration – as Finance & Operations Director with a focus on financial reporting, budgeting, HR, risk management and office operations.
Early Charm Ventures today announced the hiring of Mohan Nartu, PhD – an engineer with expertise in materials science – as Scientist-Ceramics and Additive Manufacturing. Nartu’s work will center on Early Charm’s Materic company, Synteris, with a focus on driving technical advancement of Synteris’s 3D-printable ceramic packaging for power electronic modules.
Optave Diagnostics, a technology company developing an endoscopic probe device that uses photoacoustic imaging (PAI) to aid in cancer detection and diagnosis, today announced it has been awarded a $256,000 Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation (NSF).
Early Charm Ventures, a company that creates, owns and operates ventures that convert science to revenue, today welcomed Rashi Sultania – a chemical and biomolecular engineer – as Research Associate focusing on R&D and product development for Early Charm’s advanced materials and drug design portfolio of companies.
Early Charm is a venture studio that converts science to business. We specialize in turning brilliant scientific discoveries into companies focused on growth. We don’t chase quick exits. We grow companies that create sustainable value.
1300 Bayard St.
Baltimore, MD 21230